Towards “actively developing and expanding into new market segments,” the expanded company, in which Bayer has the ... Each will have its own logo in combination with the Bayer cross. Applications ...
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
Bayer Cropscience Ltd. key Products/Revenue Segments include Insecticides, Pesticides, Herbicides, Weedicides & Fungicides, Other Operating Revenue, Scrap and Royalty Income for the year ending 31-Mar ...
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...
The Quarterly Results page of Bayer Cropscience Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback